関連する実験動画

Updated: May 9, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.7K

ヒトの表皮成長因子受容体2-低乳がん:病理学者の間で発生率とスコアコンコードンス

Maher Sughayer1, Ghada Al-Jussani2, Ahmed Salem3

  • 1Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan.

Breast cancer : basic and clinical research
|August 27, 2025
PubMed
まとめ

HER2値が低い乳がんはヨルダンで一般的であり,病理学者はスコアに実質的な合意を示しています. この発見は,重要な患者集団に対する抗HER2治療の決定を導く上で極めて重要です.

キーワード:
乳がんHER2 についてHER2値が低いキング・フセイン・ガンセンターコンセンサススコアリング

さらに関連する動画

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

273

関連する概念動画

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...